Seth Lederman

Seth Lederman

Directeur Général chez TONIX PHARMACEUTICALS HOLDING CORP.

Fortune : 302 008 $ au 30/09/2026

68 ans
Health Technology
Consumer Services
Commercial Services

Profil

Seth Lederman founded Ivrea Pharmaceuticals, Inc. in 2005, Tonix Pharmaceuticals, Inc. in 2007, where he is working as Chairman & President from 2010, Tonix Pharmaceuticals Holding Corp.
in 2007, where he is working as Chairman, President & Chief Executive Officer from 2011, and various other companies.
Dr. Lederman also founded Validus LLC, where he worked as Chairman and Vela Pharmaceuticals, Inc., where he worked as Chairman from 2007 to 2008.
Dr. Lederman also currently works at Starling Pharmaceuticals, Inc., as Chairman & Chief Executive Officer from 2011, Krele LLC, as Chairman from 2010, Tonix Pharmaceuticals (Canada), Inc., as President & Director from 2013, and various other companies.
Dr. Lederman also formerly worked at Tamandare Explorations, Inc., as Chairman, President & Chief Executive Officer in 2011, Leder Laboratories, Inc., as Chairman & Chief Executive Officer from 2011 to 2018, Validus Pharmaceuticals LLC, as Chairman from 2007 to 2008, and various other companies.
Dr. Lederman received his undergraduate degree in 1979 from Princeton University and doctorate degree in 1983 from Columbia University College of Physicians & Surgeons.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
27/08/2026 31 007 ( 0,26 % ) 302 008 $ 30/09/2026

Postes actifs de Seth Lederman

SociétésPosteDébut
TONIX PHARMACEUTICALS HOLDING CORP. Directeur Général 16/11/2007
Tonix Pharmaceuticals (Canada), Inc.
President 01/04/2013
Starling Pharmaceuticals, Inc.
Directeur Général 01/12/2011
Lederman Seth Co. LLC
Corporate Officer/Principal 01/01/2007
Président 16/08/2010
Fondateur 07/06/2007

Anciens postes connus de Seth Lederman

SociétésPosteFin
L&L Technologies, Inc.
Corporate Officer/Principal 01/03/2025
Corporate Officer/Principal 01/03/2025
Lederman & Co. LLC
Corporate Officer/Principal 01/03/2025
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░ ░░ ░░░ ░░░░ ░░ ░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Seth Lederman

Formation de Seth Lederman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

63

Relations au 1er degré

28

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées28

Health Technology

Health Technology

Retail Trade

Non-Energy Minerals

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Targent Pharmaceuticals LLC

Lederman & Co. LLC

L&L Technologies, Inc.

Health Technology

Commercial Services

Validus LLC

Lederman Seth Co. LLC

Leder Laboratories, Inc.

Starling Pharmaceuticals, Inc.

Consumer Services

Tonix Pharmaceuticals (Canada), Inc.

Tonix Pharmaceuticals (Barbados) Ltd.

Health Technology

Tonix Pharma Holdings Ltd.

Fontus Pharmaceuticals, Inc.

Finance

Finance

Konanda General Partner LLC

  1. Bourse
  2. Insiders
  3. Seth Lederman
🔇